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ABSTRACT OF THE DISSERTATION 
 
Screening Adherence and Emotional Adjustment of 
Daughters of Breast Cancer Patients 
by 
Sarah R. Ormseth 
Doctor of Philosophy, Graduate Program in Clinical Psychology 
Loma Linda University, September 2013 
Dr. Adam Aréchiga, Chairperson 
 
Women at high risk for breast cancer oftentimes also experience psychological 
vulnerably related to experiences of cancer in their family, high bereavement rates and 
their own uncertainties regarding if and when they may develop the disease. This 
research sought to evaluate psychological adjustment and examine reattendance among a 
sample of women adhering to regular breast cancer surveillance, with a specific focus on 
daughters of breast cancer patients. The study described in Chapter 2 longitudinally 
profiled anxiety and depressive symptoms among these high-risk daughters across three 
consecutive surveillance appointments, and also evaluated the effects of a set of 
hypothesized predictors on change in symptomatology. The results showed an overall 
decrease in anxiety over the course of the three surveillance visits, as well as a marginally 
significant decrease in depressive symptoms. When the effects of moderating variables 
on symptom change were examined, results demonstrated that some subgroups of 
daughters differentially benefited from the high-risk program, with daughters whose 
mothers died who were older at the time of their mother’s diagnosis being the only group 
that did not appear to experience decreases in symptomatology. The study presented in 
Chapter 3 investigated psychosocial correlates of reattendance at the high-risk clinic, 
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again focusing on daughters of breast cancer patients. Results showed that greater 
likelihood of reattendance was associated with hypothesized predictors, including older 
age, lower depressive symptoms and maternal loss to breast cancer. Moreover, mother’s 
survival status was found to moderate the effect of perceived risk on likelihood of 
reattendance such that higher perceived risk predicted increased reattendance for 
daughters whose mothers survived, but not those whose mothers died. Additionally, 
results indicated that the association between anxiety and likelihood of reattendance was 
non-linear in nature (inverted “U”); reattendance was more likely among daughters with 
moderate anxiety compared to those with low or high anxiety. Findings from these 
studies contribute to a greater understanding of psychological adjustment and screening 
adherence of women at high-risk for breast cancer and may inform the development of 
targeted interventions to promote screening adherence and psychosocial wellbeing among 
this and other vulnerable high-risk populations.  
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CHAPTER ONE 
INTRODUCTION 
 
Despite recent progress in early detection and treatment, breast cancer remains a 
serious health concern. Excluding skin cancer, breast cancer is the most frequently 
diagnosed cancer in women and ranks second as a cause of cancer death, with 234,580 
new cases and 40,030 breast cancer deaths expected in 2013 in the United States (Siegel, 
Naishadham, & Jemal, 2013). Family history of breast cancer is a significant risk factor 
for development of the disease, particularly for women with first-degree relatives 
diagnosed with breast cancer (Calle, Martin, Thun, Miracle, & Heath, 1993; Sattin et al., 
1985; Sellers et al., 1999; Slattery & Kerber, 1993). A woman’s breast cancer risk 
approximately doubles if a first-degree relative, such as a mother, has been diagnosed. 
Women with a family history of breast cancer are at higher risk for breast cancer than the 
general population because of shared genetic factors and possibly because of shared 
exposures to environmental and lifestyle risk factors (Easton, 2002; Slattery & Kerber, 
1993).  
A number of general and cancer-related psychosocial difficulties may also be 
associated with high-risk status. Many women at high risk for breast cancer experience 
elevated levels of general anxiety (Lindberg & Wellisch, 2001) and report levels of 
distress significant enough to warrant psychological counseling (Kash, Holland, Osborne, 
& Miller, 1995), which can negatively affect quality of life. Furthermore, research has 
shown that high-risk women overestimate their risk of developing breast cancer 
(Katapodi, Lee, Facione, & Dodd, 2004), experience higher levels of anxiety related to 
cancer screening (Lindberg & Wellisch, 2001), express greater concern about breast 
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cancer, and endorse less confidence in available treatment methods for the illness 
(Cappelli et al., 2005; Wellisch et al., 1999). Psychosocial distress among women at high 
risk for breast cancer warrants concern given its influence on quality of life, as well as its 
negative impact on cancer screening adherence (Hay, McCaul, & Magnan, 2006). 
Screening for breast cancer in high-risk women may include mammography, 
clinical breast examination, breast self-examination, and more recently, magnetic 
resonance imaging. While research is mixed regarding which of the various screening 
methods and technologies is most effective, some form of regular screening is necessary 
to permit early breast cancer detection in women at higher familial risk of breast cancer. 
While regular screening for high risk women is important, the importance of the setting 
in which screening occurs is also receiving increasing recognition. The need for 
centralized multidisciplinary care of women at high risk for breast cancer has resulted in 
recommendations for, and the development of, such clinics (Kuschel, Lux, Goecke, & 
Beckmann, 2000). This stems from recognition of some problems that may be associated 
with ongoing cancer surveillance through individual private specialists in a non-
multidisciplinary context (Antill, Shanahan, & Phillips, 2005). For example, it may be 
inconvenient for a woman to attend multiple specialists and diagnostic facilities on 
different days and in different locations. A decentralized arrangement may also hinder 
coordination of care. Additionally, it may be difficult for some women to independently 
locate breast specialists with particular expertise in high-risk populations. 
The UCLA Revlon Breast Center High Risk Clinic is a multidisciplinary center 
that setting that serves patients at familial risk for breast cancer. Patients are seen once or 
twice a year for a personalized surveillance program, based on individual risk factors. A 
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multidisciplinary team manages patient care, including a nurse practitioner to perform a 
breast exam, teach breast self-examination, and order same day diagnostic tests such as a 
mammogram, ultrasound or MRI as needed. A medical oncologist will offer counsel 
about breast cancer risks risk reduction strategies. A Genetic counselor will also provide 
education and counseling. 
Additionally, patients are seen by specialists whose services may be more difficult 
to obtain outside the context of a multidisciplinary clinic. A physician nutritionist, who 
specializes in cancer risk, makes recommendations for modifying diet. This is important 
because research is increasingly showing the association between diet and lifestyle and 
risk for developing breast cancer. Significantly, patients are also seen by a psychologist 
to discuss the feelings associated with being at high risk, and about coping with illness 
and loss of family members to breast cancer. Psychologists and other mental health 
professionals are uniquely qualified to help address many potential barriers to care among 
high-risk women. 
Drawing on data from the UCLA-Revlon High Risk Program, two papers were 
conceptualized and written focusing on important yet understudied aspects of 
psychological adjustment and healthcare utilization among women at high risk for breast 
cancer, namely daughters of breast cancer patients. In a longitudinal study of the 
psychological adjustment of these women across consecutive high risk clinic 
appointments, the first study (Chapter 2) sought to determine the pattern of anxiety and 
depressive symptoms of these daughters across the clinic visits, particularly decreases (or 
increases) in symptom severity which may be reflective of positive (or negative) 
outcomes related to adhering to regular surveillance appointments. In a second study 
 4 
(Chapter 3), predictors of reattendance to the high risk clinic were explored in an effort to 
profile patients who may be at greater risk for not returning for follow-up appointments 
for continued surveillance given their high risk status. 
 To the best of our knowledge, no other studies have examined predictors of 
reattendance to a high-risk clinic, or long term psychological adjustment of women at 
high risk for breast cancer across multiple surveillance appointments. The utility of 
focusing on and striving to better understand issues of relevance to daughters of breast 
cancer patients is evident in its potential to enhance the health, wellbeing and quality of 
life in this population, women with a family history of breast cancer, and individuals who 
are at increased hereditary risk for other cancers and diseases.  
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CHAPTER TWO 
EVOLUTION OF EMOTIONAL SYMPTOMS OF DAUGHTERS 
OF BREAST CANCER PATIENTS 
 
Sarah Ormseth, M.A., David Wellisch, Ph.D., Adam Aréchiga, Psy.D., DrPH 
 
Abstract 
This study longitudinally profiled anxiety and depressive symptoms of daughters 
of breast cancer patients, and examined mother’s survival status, daughter age at time of 
mother’s diagnosis, and style of family communication about breast cancer as moderators 
of change in symptomatology across participants’ first three appointments at the UCLA 
Revlon Breast Center High Risk Clinic. To evaluate the effects of hypothesized 
predictors on change in anxiety and depressive symptoms, 3 (symptomatology at first, 
second, and third clinic visits) × 2 (mother survived or died) × 2 (< 20 years or ≥ 20 years 
old at diagnosis) × 2 (open or closed family communication) repeated measures 
ANOVAs were employed. Results showed a main effect for time on state anxiety, 
demonstrating a significant reduction in anxiety across clinic visits overall (p < .001). 
There were also significant 3-way interactions. For state anxiety, mother’s survival status 
moderated the Time × Age at Diagnosis and Time × Family Communication interaction 
effects. For daughters whose mothers died, decreased anxiety was observed in those who 
were younger at the time of diagnosis (p = .001). For daughters whose mothers survived, 
anxiety was decreased for those with closed family communication styles (p = .001). The 
Time × Mother’s Survival × Age at Diagnosis interaction was also significant for 
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depressive symptoms (p = .001). Among daughters whose mothers died, those who were 
younger showed decreases in symptoms (p = .004). Overall, these daughters appeared to 
benefit from the high-risk program as demonstrated by decreased symptomatology, 
particularly daughters whose mothers died who were younger at the time of diagnosis. 
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Introduction 
In addition to the psychological distress often experienced by children of cancer 
patients (Visser, Huizinga, van der Graaf, Hoekstra, & Hoekstra-Weebers, 2004;  Watson 
et al., 2005), daughters whose mothers are diagnosed with breast cancer must also cope 
with learning of their own heightened susceptibility to the disease (Facione, 2002; Raveis 
& Pretter, 2005). These daughters and other women with a strong family history of breast 
cancer face ambiguity and threat about if and when cancer will develop, as well as 
decisions about how to manage this increased risk. Risk-reducing surgery and 
chemoprevention significantly reduce breast cancer risk, but uptake of these strategies is 
low (Schwartz et al., 2012). Screening and surveillance remain the mainstay of 
management for most women at increased breast cancer risk (Field & Phillips, 2007). 
Because women at high risk for breast cancer experience greater levels of general and 
cancer-specific distress (Baider, Ever-Hadani, & Kaplan De-Nour, 1999; Bovbjerg & 
Valdimarsdottir, 2001; Gilbar, 1998; Zakowski et al., 1997), some concern exists about 
the potential psychological burden of long term breast cancer surveillance. 
Increased distress is common for many high-risk women the day of screening 
appointments (Valdimarsdottir et al., 1995; Zakowski et al., 1997). In general though, 
research has not evidenced lasting adverse psychological outcomes related to breast 
cancer screening among high-risk women (Brédart et al., 2012; Rijnsburger et al., 2004; 
Watson, Henderson, Brett, Bankhead, & Austoker, 2005). Findings from a large, 
prospective cohort study of women with a family history of breast cancer showed 
significant decreases in distress six months after mammography (Brain et al., 2008; 
Tyndel et al., 2007). Although research of the effects of adhering to a breast cancer 
 8 
surveillance program is more limited, findings from the Dutch magnetic resonance 
imaging screening (MRISC) study of women at increased breast cancer risk have 
demonstrated short term reductions in distress following two successive screening 
appointments (van Dooren et al., 2005), as well as long term reductions in intrusion and 
avoidance (den Heijer et al., 2013). 
While most women with a family history do not appear to experience significant 
distress associated with breast cancer surveillance, some are more prone to persistent 
adjustment difficulties and may benefit from additional psychosocial support. Research 
suggests that several demographic, clinical and psychological factors may influence 
adjustment to breast cancer surveillance (den Heijer et al., 2013; Gopie, Vasen, & 
Tibben, 2012; van Dooren et al., 2005). Mother’s breast cancer diagnosis and/or death 
from breast cancer are well-established risk factors for maladaptation among high-risk 
women (Erblich, Bovbjerg, & Valdimarsdottir, 2000; Thewes, Meiser, Tucker, & 
Schnieden, 2003; Wellisch, Gritz, Schain, Wang, & Siau, 1991; Wellisch, Ormseth, 
Hartoonian, & Owen, 2012). In studies of psychological adjustment in the context of 
breast cancer screening, death of a close relative to breast cancer has been found to be 
associated with increased levels of cancer-specific distress (Brain et al., 2008; den Heijer 
et al., 2013). Given the unique psychosocial burden faced by daughters whose mothers 
have been diagnosed with breast cancer (Raveis & Pretter, 2005; Thewes et al., 2003), it 
seems important for research to further examine the specific impact of maternal loss to 
breast cancer on emotional response to surveillance. 
For women with a family history of breast cancer, other aspects of their 
experiences of breast cancer in their family may moderate the psychological effects of 
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surveillance. The salience of specific risk factors varies according to the developmental 
phase of a woman at the time of the diagnosis of a parent and/or loss of a first degree 
relative. Studies of daughters of breast cancer patients have shown greater adjustment 
difficulties among women who were younger at the time mother’s diagnosis (van 
Oostrom et al., 2006; Wellisch, Gritz, Schain, Wang, & Siau, 1992), and whose mothers 
died of breast cancer at a younger age (Erblich et al., 2000; Esplen & Hunter, 2002). 
Previous research has also shown that that open family communication regarding breast 
cancer has a positive effect on general and breast cancer specific distress (den Heijer et 
al., 2011), as well as short- and long-term adjustment to genetic testing (van Oostrom et 
al., 2007; van Oostrom et al., 2003). To our knowledge however, no previous study has 
investigated the impact of factors related to women’s experiences of breast cancer in their 
family on adjustment to breast cancer surveillance among daughters whose mothers have 
been diagnosed with breast cancer. 
The main aim of this study was to longitudinally profile the course of depression 
and anxiety symptoms of daughters of breast cancer patients across three consecutive 
biannual surveillance appointments at a high risk breast cancer clinic. It also was the 
intent of this study to examine potential moderators of change in symptomatology over 
time. To accomplish these goals, four hypotheses are proposed. We expected that a 
higher level of depressive symptomatology would be observed among daughters whose 
mothers died from breast cancer at baseline. Second, it was anticipated that a significant 
reduction in anxiety symptoms, but not depressive symptomatology, would be observed 
over the span of the clinic visits. Third, it was hypothesized that daughter’s age at the 
time of her mother’s breast cancer diagnosis would relate to the pattern of change in 
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symptoms across clinic visits such that a greater decrease in anxiety and depressive 
symptomatology would be observed among daughters who were older at the time of their 
mother’s diagnosis. Fourth, we expected that style of family communication about breast 
cancer would be related to the pattern of change in symptoms across clinic visits such 
that an open style of communication would be associated with a greater decrease in in 
anxiety and depressive symptomatology. The potential interactive effects of mother’s 
survival status, age at time of mother’s diagnosis and style of family communication 
about breast cancer were explored, though no specific hypotheses were proposed.  
 
Method 
Institutional Review Board approval was granted prior to data collection. Study 
data were obtained during participants’ first three visits to the UCLA Revlon Breast 
Center High Risk Clinic. The High Risk Clinic is a multidisciplinary setting that serves 
patients at familial risk for breast cancer. Patients are individually seen and counseled by 
an oncologist, a genetics counselor, a nurse practitioner, a nutritionist, and a psychologist. 
Women were eligible for participation if their biological mother had been diagnosed with 
breast cancer, were at least 18 years old, were English-speaking, and had never 
themselves been diagnosed with breast cancer. Following informed consent, participants 
completed baseline questionnaires assessing depression and anxiety symptoms and a 
semi-structured clinical interview in which psychosocial background information was 
obtained. The depression and anxiety symptoms questionnaires were also administered to 
participants at subsequent follow-up appointments. Data for 73 patients from the High 
Risk Clinic from were available for analyses for the current study. 
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Measures 
Information was obtained regarding the survival status of the participants’ 
mothers (survived or passed away from breast cancer), developmental stage at the time of 
their mother’s breast cancer diagnosis (less than 20 years old and 20 years of age and 
older), and whether participants felt they could talk openly about their mothers’ breast 
cancer with their families (open or closed communication). 
The State Anxiety subscale of the State-Trait Anxiety Inventory (STAI; 
(Spielberger, Gorsuch, & Lushene, 1970) was used to evaluate anxiety experienced at the 
time of assessment (“state anxiety”). The State Anxiety subscale contains 20 items and 
responses are measured on a 4-point Likert scale, with higher scores signifying the 
presence of higher levels of anxiety. The STAI manual reports high internal consistency 
for the State subscale (α = .92). For the current study, Cronbach’s alpha ranged from .86 
to .92 for the three time points. 
The Center for Epidemiologic Studies Depression Scale (CES-D;(Radloff, 1977) 
was used to assess current depressive symptomatology. It has 20 items that measure the 
frequency and intensity of depressive symptoms during the past week. Scores may range 
from of 0 to 60, with higher scores signifying the presence of more symptomatology. The 
test has adequate internal consistency (α = .85 for general population; α = .90 for clinical 
population); the Cronbach's alpha in this study varied from .89 to .93. 
Additionally, a number of variables were considered as potential covariates 
including age in years at interview, ethnicity (Caucasian or non-Caucasian), marital status 
(unmarried or married), educational attainment (high school, some college, college 
graduate, or graduate school), employment status (currently employed or unemployed), 
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number of years since mother’s diagnosis, number of relatives with a past or present 
breast cancer diagnosis, and objective breast cancer risk based on the Gail model (Gail et 
al., 1989). 
 
Statistical Analyses 
Repeated-measures analysis of variance (ANOVA) was used to assess the effects 
of survival status of the mother and a group of selected predictors on changes in anxiety 
and depressive symptomatology across participants’ first, second and third appointments 
at the high risk clinic. A number of potential covariates were considered, and any shown 
to be significantly associated with either of the outcome variables would have been 
included the multivariate models. Two 3 × 2 × 2 × 2 repeated measures ANOVAs were 
conducted with time (first, second and third clinic appointments) as the within subjects 
variable, mother’s survival status (survived or died from breast cancer), participant’s age 
at the time of her mother’s breast cancer diagnosis (< 20 years or ≥ 20 years old), and 
style of family communication about breast cancer (open or closed family 
communication style) as between subjects factors, and state anxiety (STAI State Anxiety 
subtest percentile) and depressive symptomatology (CES-D score) as the dependent 
variables. The assumption of sphericity was evaluated using Mauchly’s test and, if 
violated, degrees of freedom were corrected using the Greenhouse-Geisser correction 
factor. A full-factorial design was employed, therefore each model included main effects 
as well as all two, three and four-way interactions. Significant interaction effects were 
decomposed using simple effects post hoc analyses. 
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Results 
A total of 73 participants were included in the study. Table 1 shows background 
characteristics of the sample. The sample was balanced between women whose mothers 
died from breast cancer and those whose mother survived (n = 34 and n = 39, 
respectively). The majority of participants were Caucasian (83.56%, n = 61) and married 
(67.12%, n = 49), with an average age of 41.14 years. Additionally, the sample was 
largely employed (75.34%, n = 55) and had a college or advanced degree (76.71%, n = 
56). Participants exhibited absolute breast cancer risks moderately higher than that in the 
general population (18.72% mean calculated lifetime risk), and the average time since the 
mother’s breast cancer diagnosis was 16.44 years. With regard to the assessment of 
potential covariates, none were used as control variables in the multivariate models given 
their lack of association with either outcome variable. Moreover, significant differences 
in baseline CES-D scores were not observed between daughters whose mothers died from 
breast cancer (M = 11.40, SE = 1.84) and those whose mothers survived (M =13.64, SE = 
2.04), t(71) = 0.80, p = .425. 
An overall main effect for time on state anxiety was observed, F(1.69, 109.94) = 
12.45, p < .001. Specifically, participants showed significantly less anxiety at the first 
follow-up (M = 53.42, SE = 3.83) and second follow-up (M = 51.50, SE = 3.91) as 
compared to the initial visit (M = 65.88, SE = 2.94), ps < .001. Moreover, there was a 
significant three-way interaction between time, mother’s survival and age at diagnosis, 
F(1.69, 109.94) = 3.77, p = .033 (see Figure 1). To facilitate interpretation of this 
significant interaction, the association between time and age at diagnosis was examined 
separately among daughters whose mothers died and daughters whose mothers survived. 
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Table 1 
Summary statistics for sample and model variables (N = 73) 
Variable Mean ± SD or N (%) Range 
Sample characteristics    
Age in years 41.14 ± 9.33 20–66 
Ethnicity       
Caucasian 61 (83.56)   
Non-Caucasian 12 (16.44)   
Education       
High school  5 (6.85)   
Some college 12 (16.43)   
College graduate 28 (38.36)   
Graduate school 28 (38.36)   
Married 49 (67.12)   
Employed 55 (75.34)   
Years since mother’s diagnosis 16.44 ± 10.80 0–44.00 
Computed risk of breast cancer 18.72 ± 8.22 6.80–57.40 
Personal estimate breast cancer risk  56.29 ± 26.30 0–100 
Number of family with breast cancer 2.19 ± 1.22 1–7 
Model variables    
Mother’s survival status    
Survived 39 (53.42)  
Died from breast cancer 34 (46.58)  
Age at mother’s diagnosis    
Younger (< 20 years old) 30 (41.10)  
Older (> 20 years old) 43 (58.90)  
Family communication about breast cancer    
Open communication style 33 (45.21)  
Closed communication style 40 (54.79)  
State anxiety percentile    
Initial appointment 65.29 ± 24.10 10–100 
First return visit 52.81 ± 30.85 2–100 
Second return visit 52.43 ± 30.56 2–100 
CES-D score (depressive symptoms)    
Initial appointment 12.60 ± 11.83 0–52 
First return visit 10.12 ± 11.61 0–51 
Second return visit 9.97 ± 10.08 0–44 
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Table 2 
F values for repeated measures analyses of variance models 
 
 df 
State Anxiety 
Percentile 
 
df 
Depressive 
Symptoms 
F p  F p 
Main effects        
Time (A) 1.69, 109.94 12.45 <.001  2, 130 2.63 .076 
Mother survival (B) 1, 65 0.17 .686  1, 65 0.13 .718 
Age at mother’s diagnosis (C) 1, 65 3.26 .076  1, 65 0.05 .829 
Family communication about BC (D) 1, 65 0.50 .484  1, 65 2.16 .147 
Two-way interactions        
A × B 1.69, 109.94 0.19 .793  2, 130 1.80 .170 
A × C 1.69, 109.94 1.82 .173  2, 130 1.61 .204 
A × D  1.69, 109.94 2.77 .076  2, 130 0.33 .721 
B × C 1, 65 0.75 .388  1, 65 1.44 .235 
B × D 1, 65 0.46 .500  1, 65 5.77 .019 
C × D 1, 65 0.19 .663  1, 65 1.94 .168 
Three-way interactions        
A × B × C 1.69, 109.94 3.77 .033  2, 130 6.91 .001 
A × B × D 1.69, 109.94 4.10 .025  2, 130 1.42 .245 
A × C × D 1.69, 109.94 0.98 .366  2, 130 1.88 .157 
B × C × D 1, 65 0.24 .624  1, 65 0.39 .535 
Four-way interaction        
A × B × C × D 1.69, 109.94 0.05 .927  2, 130 0.50 .606 
 
The interaction effect stems from a significant Time × Age at Diagnosis interaction 
among participants whose mothers died from breast cancer, F(1.43, 43.01) = 5.15, p 
=.018. Participants whose mothers died who were younger at the time of diagnosis 
demonstrated a significant decrease in anxiety, F(1.24, 18.67) = 11.77, p = .001 (see 
Figure 1a), namely from the first visit (M = 64.89, SE = 4.39) to the second visit (M =  
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Figure 1.  Means plot of change in state anxiety percentile across time based on age at 
mother’s diagnosis. 
 
 
 
39.99, SE = 6.04, p = .001) as well as from the first visit to the third visit (M = 44.84, SE 
= 6.81, p = .005). For participants whose mothers survived, only the main effect of time 
emerged as significant, F(2, 70) = 6.87, p = .002, with significant decreases in anxiety 
from the first visit (M = 66.22, SE = 3.33) to the second visit (M = 52.04, SE = 4.97), p = 
.005, and from the first visit to the third visit (M = 49.93, SE = 4.88), p = .001. 
There was also a significant three-way interaction between time, mother’s 
survival and style of family communication about breast cancer, F(1.69, 109.94) = 4.10, 
p = .025 (see Figure 2). Further analyses revealed that the interaction effect was only 
present only among participants whose mothers survived breast cancer, F(2, 70) = 6.10, p 
= .004 (see Figure 2b). Follow-up contrasts showed a significant change in anxiety over 
time among participants whose mothers survived who reported a closed style of family 
communication, F(2, 28) = 9.30, p = .001, with decreases in symptomatology from the 
first visit (M = 78.86, SE = 4.37) to the second visit (M = 54.31, SE = 9.25, p = .012), 
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Figure  2.  Means plot of change in state anxiety percentile across time based on style of 
family communication about breast cancer. 
 
 
and from the first visit to the third visit (M = 46.69, SE = 9.24, p = .001). In contrast, style 
of family communication did not moderate change in anxiety among participants whose 
mothers died, F(1.43, 43.01) = 0.09, p = .855 (see Figure 2a). 
With regard to depressive symptoms, there was a marginally significant overall 
main effect for time on change in symptomatology, F(2, 130) = 2.63, p = .076, with a 
significant decrease in depressive symptoms from the initial clinic visit (M = 12.85, SE = 
1.46) to the third visit (M = 10.40, SE = 1.24), p = .032. There was also a significant 
three-way interaction between time, mother’s survival and age at diagnosis, F(2, 130) = 
6.91, p = .001 (see Figure 3). To facilitate interpretation of this interaction effect, the 
association between time and age at diagnosis was examined separately among daughters 
whose mothers died from breast cancer and daughters whose mothers survived. Follow-
up analyses indicated a significant Time × Age at Diagnosis interaction among 
participants whose mothers died, F(2, 60) = 8.26, p = .001. The effect was significant 
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Figure 3.  Means plot of change in depressive symptoms across time based on age at 
mother’s diagnosis. 
 
 
among participants whose mothers died who were younger at the time of diagnosis, F(2, 
34) = 6.63, p = .004 (see Figure 3a). Specifically, there were significant decreases in 
depressive symptoms from the first visit (M = 12.90, SE = 2.76) to the second visit (M = 
7.55, SE = 2.28, p = .015) as well as from the first visit to the third visit (M = 7.43, SE = 
1.82, p = .004). For participants whose mothers survived, only the main effect of time 
emerged as significant, F(2, 70) = 3.58, p = .033, with a significant decrease in 
depressive symptoms from the first visit (M = 14.31, SE = 2.18) to the third visit (M = 
9.76, SE = 1.77), p = .014. With regard to the effect of style of family communication on 
depressive symptoms, no main or interaction effects were shown. 
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Discussion 
This study was an attempt to longitudinally profile anxiety and depressive 
symptoms of daughters of breast cancer patients attending a high-risk breast cancer 
clinic. A number of specific effects emerged that lend further understanding to the 
influence of mother’s survival, daughter’s age at time of mother’s diagnosis, and style of 
family communication about breast cancer and their relationship to the long-term 
emotional functioning of these high-risk daughters. While results confirmed some 
significant main effects, the interaction effects were more significantly and consistently 
associated with changes in anxiety and depressive symptomatology. Overall, the findings 
underscore the importance of moderating variables in understanding the long-term 
adjustment of women with a family history of breast cancer adhering to a high-risk 
surveillance program. 
In regard to the first hypothesis, it was not the case that depressive 
symptomatology was higher at baseline, or for that matter at follow-up, among women 
whose mothers died from breast cancer. This finding may appear to fly in the face of 
“reasonable” clinical expectations. It seems reasonable to expect that women whose 
mothers died from breast cancer will enter the clinic with significantly higher levels of 
depressive symptomatology. That the baseline CES-D scores were essentially identical 
for daughters whose mothers died and daughters whose mothers survived suggests that 
the depressing and emotionally impactful aspect of the experience involves witnessing 
the mother going through the disease process. Maternal loss, therefore, is not necessarily 
the only depressing stressor in this experience. 
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The second hypothesis was supported in that a significant reduction in anxiety, 
but not depressive symptoms, was observed over the span of the three clinic visits. This 
was not unanticipated by the investigators. Anxiety is an emotional state which we are 
used to seeing dramatically changed over a brief period of time in the clinic. These 
daughters oftentimes enter the clinic with significant anxiety related to concerns about 
their own vulnerability to breast cancer and memories of their mother’s experience with 
the disease. It appears however that emotional support for women to process these issues 
facilitates a rapid and significant reduction in symptoms of anxiety. This would reinforce 
the notion elsewhere in the literature of the potential of single-session interventions to 
affect significant changes in emotional states (Hymmen, Stalker, & Cait, 2013). 
The third hypothesis was not confirmed as age at time of mother’s diagnosis, by 
itself as a predictor, was not associated with change in anxiety or depressive 
symptomatology. Significant effects were observed when age at the time of diagnosis 
was considered in terms of the moderating effects of mother’s survival status. For 
daughters whose mothers survived, the main effect for time was significant as reflected 
by decreased anxiety and depressive symptomatology. The interaction between time and 
age at mother’s diagnosis was significant among daughters whose mothers died from 
breast cancer. In particular, and contrary to our expectations, a pronounced reduction in 
anxiety symptoms was observed from the first to second clinic visits among daughters 
whose mothers died who were younger at the time of diagnosis. It appears that the 
opportunity to talk openly in the clinic context was less beneficial in reduction of anxiety 
symptoms for daughters whose mothers died who were older at the time of diagnosis. 
Research has shown that women who were older at the time of their mother’s diagnosis 
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and death experience greater role strain and caretaking responsibilities (Wellisch et al., 
1991), while women who were younger during this experience were more protected 
(Compas et al., 1994; Wellisch et al., 1992). Perhaps the women who were older require 
more intensive and supportive interventions beyond what might be possible in the context 
of the clinic visits. 
In regard to hypothesis 4, by itself as a predictor, style of family communication 
was not found to be associated with change in anxiety or depressive symptomatology 
across clinic visits. It was only when style of family communication was considered in 
interaction with mother’s survival status that it proved decisive in the data. Specifically, 
the results demonstrated that daughters whose mothers survived but whose families had a 
closed style of communication about breast cancer entered the clinic with significantly 
elevated levels of anxiety compared to daughters whose mothers survived with an open 
style of family communication and daughters with mothers who died regardless of family 
communication style. This suggests that hampered family communication about breast 
cancer, in the face of the continued presence of the mother in the household, may be 
reflective of a particularly dysfunctional dynamic. While it is fortunate that this group of 
daughters appears to derive significant benefit from the opportunity to talk about their 
experiences in their first clinic visit, this finding reminds us to more carefully consider 
the emotional experience of the daughter whose mother survived breast cancer. As 
previously discussed, adaptive versus less adaptive adjustment and functioning on the 
part of high-risk women should not be inferred solely on the basis of maternal survival 
versus maternal death from breast cancer (Wellisch et al., 2012). 
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The findings of this study should be considered in light of some limitations. The 
sample was comprised of women adhering to regular breast cancer surveillance and may 
not be generalizable to high-risk women in the community or those with limited access to 
healthcare. Additionally, the sample was predominantly Caucasian, well-educated urban 
women. Larger studies with more demographically representative samples would add 
clarity regarding the robustness of these results. Additional research to expand on the 
results of this study will further enable healthcare professionals to identify and offer 
additional support to high-risk women most vulnerable to maladjustment. 
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PREDICTING REATTENDANCE TO A HIGH-RISK  
BREAST CANCER CLINIC 
 
Sarah Ormseth, M.A., David Wellisch, Ph.D.,  
Adam Aréchiga, Psy.D., DrPH, Taylor Draper, M.A. 
 
Abstract 
Research about follow-up patterns of women attending high-risk breast cancer 
clinics is limited. The objective of this study is to profile daughters of breast cancer 
patients who are likely to return versus those unlikely to return for follow-up care in a 
high-risk clinic. This longitudinal investigation included 131 patients attending the 
UCLA Revlon Breast Center High Risk Clinic. Predictor variables included age, 
computed breast cancer risk, participants’ perceived personal risk, clinically significant 
depressive symptomatology (CES-D score ≥ 16), current level of anxiety (State-Trait 
Anxiety Inventory), and survival status of participants’ mothers (survived or passed away 
from breast cancer). Results showed that a greater likelihood of reattendance was 
associated with older age (adjusted odds ratio [AOR] = 1.07, p = .004), computed breast 
cancer risk (AOR = 1.10, p = .017), absence of significant depressive symptomatology 
(AOR = 0.25, p = .009), past psychiatric diagnosis (AOR = 3.14, p = .029), and maternal 
loss to breast cancer (AOR = 2.59, p=.034). Also, an interaction was found between 
mother’s survival status and perceived risk (p = .019), such that reattendance was 
associated with higher perceived risk among participants whose mothers survived, (AOR 
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= 1.04, p = .002), but not those whose mothers died (AOR = 0.99, p = .685). 
Furthermore, a non-linear inverted “U” relationship was observed between state anxiety 
and reattendance (p = .037); participants with moderate anxiety were more likely to 
reattend than those with either low or high anxiety levels. Findings highlight the 
importance of psychological factors in predicting reattendance to a high-risk breast 
cancer clinic. Explication of profiles of women who may or may not follow-up offers the 
possibility of intervention from the first visit to increase the likelihood of follow-up care. 
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Introduction 
For women at high risk for breast cancer, screening is the mainstay of risk 
management. Given that evidence-based cancer screening and risk reduction strategies 
for women with a family history of breast cancer are complex and dynamic, optimal risk 
management is likely to be in the context of a multidisciplinary setting (Field & Phillips, 
2007). The advantages of multidisciplinary high-risk care has resulted in 
recommendations for, and the development of, such clinics (Kuschel, Lux, Goecke, & 
Beckmann, 2000). High risk clinics provide continual surveillance, screening, and 
management for high-risk women in a centralized context. Despite the benefits of 
multidisciplinary high-risk cancer surveillance programs, many women with a family 
history of breast cancer do not attend or re-attend for continued screening and risk 
management (Hailey, Carter, & Burnett, 2000). 
While extant research has identified a number of barriers and facilitators of 
screening adherence among women at high risk for breast cancer, few studies have 
examined factors related to re-attendance. Previous studies have primarily focused on 
prior screening experiences and a limited set of demographic variables and have shown 
an association between a decreased likelihood of reattendance and reluctance at initial 
attendance, negative past screening experiences, prior mammography screening, a foreign 
language background, and greater rurality (Bulliard, De Landtsheer, & Levi, 2003; 
Cockburn, Schofield, White, Hill, & Russell, 1997; Katapodi, Lee, Facione, & Dodd, 
2004; Price et al., 2010; Tatla et al., 2003). Research on reattendance is particularly 
important considering that attendance rates tend to decline with successive screening 
(Fink, Shapiro, & Roester, 1972; Taylor, Taplin, Urban, White, & Peacock, 1995). 
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Therefore, research examining additional factors related to reattendance is essential for 
increasing rates of reattendance (Cockburn et al., 1997). 
Among high-risk women, some evidence suggests that elevated levels of distress 
and depressive symptoms relate to decreased screening adherence (Kash, Holland, 
Halper, & Miller, 1992; Price et al., 2010; Wellisch & Lindberg, 2001). While anxiety 
has been found to be related with both screening avoidance and adherence (Consedine, 
Magai, Krivoshekova, Ryzewicz, & Neugut, 2004; Hailey, 1991; Kash et al., 1992; 
Lerman et al., 1993; Lerman, Kash, & Stefanek, 1994; Lindberg & Wellisch, 2001; 
Meiser et al., 2000), there is some evidence that the anxiety-adherence relationship may 
be non-linear with likelihood of adherence declining both with increasing or decreasing 
levels of anxiety (Meiser et al., 2000; Zhang et al., 2012). Literature evaluating the effect 
of lifetime psychiatric history on reattendance behavior is more limited. However, 
consistent with the kindling hypothesis (Kendler, Karkowski, & Prescott, 1999), it might 
be expected that high-risk women with a history of depression or anxiety may be 
sensitized to stressful life events such as maternal illness and death and experience 
subsequent maladaptation. Indeed, previous research has demonstrated an association 
between past psychiatric illness and current affective difficulties among women at high 
risk for breast cancer (Hopwood et al., 1998). 
Studies have also examined perceived risk as a correlate of breast cancer 
screening among high-risk women, though findings have been inconsistent. Perceived 
risk has shown a positive association with breast cancer screening (Consedine et al., 
2004; Lerman et al., 1993; McCaul, Branstetter, O'Donnell, Jacobson, & Quinlan, 1998; 
McCaul, Schroeder, & Reid, 1996; Zhang et al., 2011), and has also been shown to be 
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unassociated with screening (Diefenbach, Miller, & Daly, 1999; Gorin & Albert, 2003; 
Isaacs et al., 2002; Martin & Degner, 2006). However, a recent comprehensive review 
about perceived risk and adherence to breast cancer screening among women with 
familial breast cancer risk reported a weak to moderate positive relationship between 
perceived breast cancer risk and mammography adherence (Walker et al., 2013).  
Demographic characteristics also likely affect screening re-attendance. Research 
indicates that older age and being married/partnered predicts screening uptake (Price et 
al., 2010; Rahman, Dignan, & Shelton, 2005), as well as reattendance for breast cancer 
screening (Pakenham, Pruss, & Clutton, 2000). Reattendance may also be related to 
aspects of women’s experiences of breast cancer in their families. Research has shown 
that women with a breast cancer death in the family were more likely to have had a recent 
mammogram compared with women with only a breast cancer survivor in the family 
(Tracy et al., 2008). However, the association between mothers’ survival from breast 
cancer and daughters’ reattendance rates to high-risk clinics has not yet been examined. 
The main aim of this study was to profile women who are likely to return versus 
those unlikely to return for follow-up care in a high risk breast cancer clinic, with a 
specific focus on daughters of breast cancer patients. A set of hypotheses emerge from 
the literature that this study can help evaluate. It was expected that demographic 
characteristics would be associated with an increased likelihood of reattendance, 
including older age and being married/partnered. Next, it was hypothesized that 
depressive symptomatology, lifetime psychiatric diagnoses, perceived breast cancer risk, 
and survival status of the mother will be associated with likelihood of reattendance. 
Specifically, an increased likelihood of reattendance was expected to be associated with 
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higher levels of perceived risk and maternal loss to breast cancer, while a decreased 
likelihood of reattendance was expected to be associated with clinically significant 
depressive symptoms and having a previous diagnosis of a psychiatric disorder. It was 
also hypothesized that the relationship between state anxiety and reattendance will be 
curvilinear in nature such that reattendance will be more strongly associated with 
moderate levels of anxiety than milder anxiety or more severe anxiety. Finally, it was 
hypothesized that survival status of the mother will moderate the effects of the 
aforementioned hypothesized predictors on likelihood of reattendance. 
 
Method 
The data for the present study were obtained during the patients’ first three 
appointments at the UCLA Revlon Breast Center High Risk Clinic. The High Risk Clinic 
is a multidisciplinary center that setting that serves patients at familial risk for breast 
cancer. During their initial visit to the clinic, patients are individually seen and counseled 
by an oncologist, a genetics counselor, a nurse practitioner, a nutritionist, and a 
psychologist; most patients also receive a mammogram. During follow-up visits, patients 
are seen by specific members of the team according to the patient’s needs. 
Institutional Review Board approval was granted prior to data collection. Women 
were eligible for participation if their biological mother had been diagnosed with breast 
cancer, were at least 18 years old, were English-speaking, and had never themselves been 
diagnosed with breast cancer. Data for 131 patients from the High Risk Clinic from were 
available for analyses for the current study. A psychologist conducted a semi-structured 
clinical interview with participants during their first appointment, in which psychosocial 
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background information was obtained. Participants also completed questionnaires 
assessing depression and anxiety symptoms during their initial appointment.  
 
Measures 
 The primary outcome variable was reattendance to the high-risk clinic, defined as 
a dichotomous measure of whether patients returned for a follow-up appointment 
(reattendance coded as 1, did not follow-up as 0). 
To ascertain their mothers’ survival from breast cancer, participants were asked 
whether their mothers were still alive, and cause of death if deceased (died from breast 
cancer coded as 1, alive or non-breast cancer death as 0). Perceived risk was assessed by 
having participants rate from 0 (not at all likely) to 100 (extremely likely) the likelihood 
that they would ever develop breast cancer. Participants were also asked about their 
lifetime history of any diagnosed psychiatric condition (previous psychiatric diagnosis 
coded as 1, no psychiatric history as 0). 
The State-Trait Anxiety Inventory (STAI; (Spielberger, Gorsuch, & Lushene, 
1970) was used to evaluate current level of anxiety (“state anxiety”). The State scale 
contains 20 items and responses are measured on a 4-point Likert scale, with higher 
scores signifying the presence of higher levels of anxiety. The STAI manual reports high 
internal consistency State scale (α = .92), which was replicated in this study (α = .90). 
The Center for Epidemiologic Studies Depression Scale (CES-D;(Radloff, 1977) 
was used to assess current depressive symptomatology. The CES-D consists of 20 items 
and scores may range from of 0 to 60, with higher scores signifying the presence of more 
symptomatology. The test has good reliability (α = .85 for general population; α = .90 for 
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clinical population); the reliability of the scale was strong in the current study (α = .95). 
Although not constituting a clinical diagnosis of depression, scores at or above 16 on the 
CES-D are considered indicative of clinically significant symptoms of depression. 
Additionally, a number of variables were considered as potential covariates 
including age in years at interview, ethnicity (Caucasian or non-Caucasian), marital status 
(married/partnered or never married/partnered), educational attainment (high school, 
some college, college graduate, or graduate school), employment status (currently 
employed or unemployed), participant age at the time of mother’s breast cancer 
diagnosis, mother’s age at the time of diagnosis, number of relatives with a past or 
present breast cancer diagnosis, and computed breast cancer risk using the Gail model 
(Gail et al., 1989). 
 
Statistical Analyses 
Analyses were conducted using SPSS 19.0. Associations between reattendance 
and potential control variables were examined using χ2 and t tests for categorical and 
continuous variables, respectively. Variables that had a significant association 
reattendance were included as covariates in the multivariate models to ascertain unbiased 
point estimates. Three multivariate logistic regression models were used to predict 
reattendance as a dependent variable, with results expressed in adjusted odds ratio 
(AORs) with 95% confidence intervals (CIs). The first model assessed likelihood of 
reattendance based on the focal main effects, after controlling for relevant covariates. 
Perceived breast cancer risk, depressive symptomatology, state anxiety percentile score, 
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personal history of a psychiatric diagnosis, and survival status of participants’ mothers 
were included in the model as main effects.  
Next, to test the moderating effects of mother’s survival status, the two-way 
interactions of survival status with perceived risk and the other focal predictors were 
considered. Continuous predictors were mean centered prior to creating interaction terms 
(Aiken & West, 1991). Preliminary analyses revealed three non-significant interaction 
terms (survival × state anxiety, survival × depression, and survival × past 
psychopathology, Fs < 1). Thus, these terms were trimmed, and the significance of the 
survival status × perceived risk interaction effect was tested in the multivariate model. In 
may be non-linear. Quadratic anxiety scores were computed by squaring the centered 
state anxiety scores. Likelihood ratio tests were used to determine whether the increment 
in the proportion of variance accounted for by addition of the higher-order terms was 
statistically significant. Statistically significant interaction and quadratic effects were 
depicted graphically using locally weighted scatterplot smoothing (Lowess) to facilitate 
the visual interpretation of the plots (Cleveland, 1979). 
 
Results 
A total of 131 (65 reattended; 66 did not return) participants were included in the 
study. Table 5 shows background characteristics of the sample. With respect to age, the 
overall sample was relatively young (M = 39.85, SD = 10.10) and exhibited absolute 
breast cancer risks moderately higher than that in the general population (18.24 percent 
calculated lifetime risk). Additionally, the majority of participants were Caucasian 
(81.68%, n = 107), married (61.07%, n = 80), and had a college or advanced degree  
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Table 5 
Demographic characteristics of participants who returned for a follow-up 
appointment compared to those who did not 
 Total Sample  Attended Follow-up Appointment 
Variable 
 
(N = 131)  Yes (n = 65)  No (n = 66) 
M ± SD or n (%)  M ± SD or n (%)  M ± SD or n (%) 
Age in years* 39.85 ± 10.10   42.75 ± 9.23  36.99 ± 10.17 
Marital status*         
Married or partnered 82 (62.60)  50 (76.92)  32 (48.49) 
Not married or partnered 49 (47.40)  15 (23.08)  34 (51.51) 
Ethnicity         
Caucasian 107 (81.68)  54 (83.08)  53 (80.30) 
Non-Caucasian 24 (18.32)  11 (16.92)  13 (19.70) 
Education         
High school  8 (6.11)  3 (4.62)  5 (7.58) 
Some college 18 (13.74)  12 (18.46)  6 (9.10) 
College graduate 48 (36.64)  21 (32.31)  27 (40.91) 
Graduate school 57 (43.51)  29 (44.62)  28 (42.42) 
Employment status         
Unemployed 30 (22.90)  13 (20.00)  17 (25.76) 
Employed 101 (77.10)  52 (80.00)  49 (74.24) 
Computed breast cancer risk* 18.24 ± 7.15  19.62 ± 9.20  16.87 ± 3.88 
Number of relatives with BC 2.12 ±1.21  2.15 ± 1.29  2.08 ± 1.27 
Age at mother’s diagnosis 24.18 ± 11.80  24.98 ±11.69  23.40 ± 11.94 
Mother’s age at diagnosis 51.35 ± 11.94  50.32 ±12.87  52.40 ±10.90 
*p < .05 for differences between participants who did and did not reattend. 
 
(80.15%, n = 105). The background characteristics of these two groups were generally 
similar. However, compared to participants who returned for a follow-up appointment, 
participants who did not reattend were younger (t(129) = -3.40, p = .001), less likely to be 
married (χ2(1)=11.31, p = .001) and had a lower computed breast cancer risk (t(129) = -
2.22, p = .029). Given these findings, age, marital status and computed breast cancer risk 
were used as control variables. 
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The main effects model discriminated well between patients who did and did not 
return for follow-up, 2(8) = 45.89, p < .001, and accounted for 39.4% of the variance in 
reattendance (Nagelkerke R2 = 0.39). The coefficients for seven of the eight hypothesized 
predictors were statistically significant (p < .05). Odds ratios for the independent 
variables are presented in Table 6. When holding other variables constant, this model 
suggests that likelihood of reattendance increased by eight percent for each one year 
increase in age, and each one standardized unit increment in computed breast cancer risk 
was associated with an 11 percent rise in likelihood of reattendance. For each one 
standardized unit increment in perceived breast cancer risk, likelihood of reattendance 
increased by two percent. Participants with clinically significant distress were only about 
21 percent as likely to reattend as those did not demonstrate marked depressive 
 
 
Table 6 
Sample characteristics and multivariate logistic regression predicting reattendance 
 Attended Follow-up Appointment  Multivaraite  
Logistic Regression 
Variable 
Yes (n = 65)  No (n = 66)  
M ± SD or n (%)  M ± SD or n (%)  AOR (95% CI) p 
Age in years 42.75 ± 9.23  36.99 ± 10.17  1.07 (1.02–1.13) .004 
Computed breast cancer risk 19.62 ± 9.20  16.87 ± 3.88  1.10 (1.02–1.20) .017 
Married or partnered 50 (76.92)  32 (48.49)  1.98 (0.80–4.88) .141 
Significant distress (CES-D) 12 (18.46)  23 (34.85)  0.25 (0.09–0.71) .009 
Prior psychiatric diagnosis 22 (33.85)  14 (21.21)  3.14 (1.13–8.74) .029 
State Anxiety percentile 64.24 ± 7.70  66.08 ± 9.50  0.95 (0.90–1.00) .049 
Perceived breast cancer risk 56.77 ± 24.81  48.27 ± 24.99  1.02 (1.00–1.04) .035 
Maternal breast cancer loss 35 (53.85)  23 (34.85)  2.59 (1.08–6.23) .034 
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symptomatology. For each one percentile increase in state anxiety, likelihood of 
reattendance decreased by five percent. Finally, the likelihood of reattendance among 
participants who reported a past psychiatric diagnosis was over three times as large as 
those without a psychiatric history, and the likelihood of reattendance among participants 
whose mothers died from breast cancer was almost three times that of participants whose 
mothers survived breast cancer. 
In addition to main effects, the interaction of survival status and perceived risk 
was also assessed. While the significance of all other previously present predictors 
remained virtually unchanged, entry of this interaction term into the multivariate model 
significantly improved the fit over the main effects only model, χ2inc(1) = 5.53, p = .019, 
Nagelkerke R2 = 0.43. This suggests that the association between perceived risk and 
likelihood of reattendance was moderated by mother’s survival status. To facilitate 
interpretation of this significant interaction effect, the association between perceived risk 
and likelihood of reattendance was examined separately among daughters whose mothers 
died from breast cancer and daughters whose mothers survived (see Figure 4). Analyses 
revealed that higher perceived risk was associated with a greater likelihood of 
reattendance among participants whose mothers survived breast cancer (p = .002, AOR = 
1.04, 95% CI: 1.01–1.07). In contrast, no association was shown between perceived risk 
and reattendance among participants whose mothers died (p = .685, AOR = 0.99, 95% 
CI: 0.97–1.02). This interaction effect is illustrated in Figure 4, which shows predicted 
probabilities of reattendance based on perceived breast cancer risk, stratified by mother’s 
survival status.  
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Figure 4. Predicted probability of reattendance as function of perceived breast cancer 
risk for daughters whose mothers survived and died from breast cancer (plotted using 
Lowess smoothing with bandwidth 0.8). 
 
To assess nonlinearity in the association between state anxiety and likelihood of 
reattendance, a quadratic effect for state anxiety term was introduced to the multivariate 
logistic regression model. As previously discussed, the linear state anxiety term was 
significantly associated with reattendance in the main effects model (see Table 6). When 
the quadratic term was entered into the model, all previously significant main effects 
remained as such, including the linear state anxiety term (p = .049, AOR = 0.95, 95% CI: 
0.90–0.99). The quadratic state anxiety term was also shown to be significant (p = .037, 
AOR = .99, 95% CI: 0.99–1.00), and the addition of this term resulted in a significant 
model improvement, χ2inc(1) = 6.26, p = .012, Nagelkerke R2 = 0.44, demonstrating that a  
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Figure 5. Estimated predicted probability of reattendance as function of state anxiety 
percentile scores (plotted using Lowess smoothing with bandwidth 0.8). 
 
nonlinear relationship better described the data. A figure examining the association 
between state anxiety and likelihood of reattendance plotted the predicted probability of 
reattendance as a function of state anxiety. As shown in Figure 5, the peak probability of 
reattendance implied by the model occurs at a state anxiety percentile of about 60, with 
reattendance declining both with increasing or decreasing levels of state anxiety. 
 
Discussion 
As predicted, demographic characteristics were found to be related to clinic 
attendance. Specifically, our hypothesis that increased age and being married/partnered 
would be associated with reattendance was in fact borne out by the data. Though not 
significant in in multivariate analyses, the finding that greater reattendance was observed 
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among participants who were married/partnered supports the results of previous studies 
(Pakenham et al., 2000). Some suggest that a stable relationship provides the social 
support that is often related to higher levels of adherence with health recommendations 
(Lerman, Rimer, Trock, Balshem, & Engstrom, 1990). Age was significant in the 
multivariate model and, holding all other variables constant, it was found that each year 
of increased age was associated with a seven percent greater likelihood of reattendance; 
likelihood of reattendance doubled with each decade of age. This agrees with the thrust of 
the literature that older age is predictive of greater reattendance as well as adherence to 
breast cancer screening practices such as mammography (Pakenham et al., 2000; Price et 
al., 2010; Rahman et al., 2005). We view this as logical because older patients would 
have more stability and security in their lives personified by long-term committed 
relationships, having children, and more established career patterns. These life issues help 
support such older patients in facing the anxiety of high risk status and clinic attendance, 
and offer more reason to live, thus reinforcing the possibility of clinic reattendance. We 
have often been told by patients in the clinic that a key reason for them to keep 
reattending is to identify any possible breast cancer early to allow them to be there for 
their children and grandchildren. 
Clinically significant depressive symptoms turned out to be among the most 
significant predictors of non-reattendance to the clinic. Our hypothesis was supported in 
that those patients with clinically significant depressive symptomatology (CES-D score 
of 16 or higher) were only 25 percent as likely to return for follow-up. In our view, 
reattendance to the clinic requires motivation, energy, cognitive organization, emotional 
resilience and other factors that are depleted by the existence of significant depressive 
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symptomatology. This begins to make a case for measuring depression at baseline in 
clinics such as this, and with patients found to have CES-D scores above 16, to be given 
additional attention. This might be characterized by offering them more emotional 
support, time with a clinic mental health professional in the first visit, and more diligent 
call backs to ensure that patients schedule and attend follow-up appointments. 
Additionally, efforts can be made to link them up with outside mental health systems to 
so as not to take a wait and see approach but to take action on day one given such a 
clinical finding.  
For patients with a CES-D score of 16 or greater, clinicians may consider 
reviewing the endorsed items with the patient in the first consultation session. For 
example, if a patient is endorsing significant sleep difficulties, we recommend attempting 
to understand what is occurring, why this is occurring, and discussing with the patient 
about pragmatic interventions and even strategies she can take home from the first clinic 
consultation visit. We view this kind of collaborative problem solving as useful in 
creating a bond with the patient and helping to instill hope that her concerns will be heard 
and addressed, thus leading to increased motivation to return for future visits.  
With regard to our hypothesis about a previous diagnosis of a psychiatric 
condition, we appear to have been dramatically mistaken in our prediction. Unexpectedly, 
a history of a psychiatric diagnosis proved to be predictive of substantially greater 
likelihood of clinic reattendance. The data showed that having one or more previous 
psychiatric diagnoses increased likelihood of clinic reattendance by a factor of three. This 
is in sharp contrast to the finding that current clinically significant symptoms of 
depression eventuated in significantly less likelihood of reattendance. However, it is 
 45 
important to note that having a previous psychiatric diagnosis does not equate necessarily 
to having a current psychiatric diagnosis. Moreover, the presence of anxiety and 
significant depressive symptomatology were statistically controlled for in consideration 
of the effects of this variable. It is possible that having had a previous diagnosis sensitizes 
one to the value and need for clinical care, and that such patients are likely to be more 
motivated and more accepting of clinical care in a situation such as the high risk clinic. 
This is not to imply that we take these past diagnoses lightly, but view them as being a 
potential positive prognostic factor in the formation of the treatment alliance with the 
clinic. These findings suggest that such history should not be considered as a rule out 
factor that would preclude continuity of care, but perhaps as an asset and motivating 
factor in continuity of care. 
The hypothesis that maternal loss to breast cancer would predict higher likelihood 
of compliance with clinic attendance was basically borne out in the data analysis. This 
finding is consistent with existing research showing that loss of a close family member to 
breast cancer may motivate reattendance and adherence to cancer screening 
recommendations (Tracy et al., 2008). By itself, it is a powerful predictor with results 
indicating that participants who lost their mothers to breast cancer were over 2.5 times 
more likely to attend a follow-up appointment. However, and as posited in the final 
hypothesis, the data in this study reflect the fact that this variable cannot be considered in 
isolation but should be considered in an interactional context with other relevant 
predictors.  
We considered this variable in relation to perceived risk and in doing so 
discovered that perceived risk differentially impacts on reattendance according to 
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maternal loss. Results demonstrated that mother’s survival status moderated the 
relationship between reattendance and perceived risk such that a higher level of perceived 
risk was associated with a greater likelihood of reattendance only for participants whose 
mothers survived breast cancer. This finding has sensitized us to be more attentive to 
patients whose mothers survived who perceive themselves at lower risk. The data show 
that these daughters are significantly less likely to return, even though their actual risk 
may be higher than they perceive. For the women whose mothers died from breast 
cancer, perceived risk become somewhat of a moot point in predicting clinic return. They 
are more likely to reattend regardless of level of perceived risk. It appears that the fact 
their mothers died from breast cancer is decisive in their patterns of reattendance. 
With regard to the hypothesis that the association between anxiety and 
reattendance will be curvilinear, this was robustly supported by the data. It was clearly 
shown that when anxiety reaches a clinically elevated level, it profoundly affects the 
likelihood of clinic reattendance. Previous literature has shown anxiety to negatively 
affect breast cancer surveillance (Kash et al., 1992). However, we felt it was necessary to 
examine the role of anxiety in a curvilinear fashion in regard to the complexity of issues 
of reattendance. It is evident, in our data, that a certain level of anxiety is motivating and 
facilitative of clinic attendance and reattendance. There is literature which shows that the 
effects of anxiety on adherence to recommended screening practices is best considered as 
an inverted “U” (Zhang et al., 2012).  
Similar to the data we found and discussed earlier on depressive symptoms, this 
data on state anxiety symptoms has sensitized us to the need to carefully identify and 
consider immediate intervention with the patient showing significant clinical anxiety on a 
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screening measure such as the State Trait Anxiety Inventory. At the middle part of the 
anxiety curve, we have learned to perceive anxiety as a motivating and facilitating feature 
in regard to clinic reattendance. Too little anxiety and too much anxiety appear to place 
patients at an increased risk for non-reattendance. Therefore, in addition to identifying 
patients who are overwhelmed with anxiety, we have learned to be equally concerned 
with identification of patients with seemingly too little anxiety appropriate to the context 
of our clinical situation. It may be that patients endorsing minimal levels of anxiety are 
utilizing the defense mechanisms of denial, suppression, or repression in ways that do not 
facilitate the optimal adherence with their clinical care. With regard to the patients with 
clearly identifiable severe anxiety, we see the necessity of extra and intensive 
interventions starting from the point of the initial visit. Anxiety may be related to post-
traumatic stress disorder which has been previously identified in women at high risk who 
have witnessed fatal breast cancer in their mother or other close family relatives 
(Lindberg & Wellisch, 2001). It is essential that such patients be offered anxiety 
management interventions starting from the baseline visit to the clinic. This may be 
particularly necessary in helping such patients deal with issues such as breast self-
examination, mammography, and integration of risk information (Kash et al., 1992). 
It is important to take some limitations into consideration when interpreting the 
findings from the present study. The demographics of the study sample were weighted 
toward Caucasian, highly educated, married women, thus limiting generalizability to 
other populations. Additionally, it cannot be assumed that the subset of patients who did 
not return to the high risk clinic did not get other types of surveillance in another clinical 
setting. In future studies, the assessment of depression, anxiety, and past psychiatric 
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history should be strengthened through use of the Structured Clinical Interview for the 
Diagnostic Statistical Manual modules for Major Depressive Disorder, Generalized 
Anxiety Disorder, and Post-Traumatic Stress Disorder, at a minimum, as well as a more 
detailed questionnaire regarding general past psychiatric history. 
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CHAPTER FOUR 
CONCLUSION 
 
The emergence of multidisciplinary high risk clinics offer significant promise for 
women with a familial risk for breast cancer. Familial risk is especially high for women 
with first-degree relatives, such as those with mothers diagnosed with breast cancer 
(Calle et al., 1993; Sattin et al., 1985; Sellers et al., 1999; Slattery & Kerber, 1993). High 
risk clinics provide continual surveillance, screening, and management for these women 
using a multidisciplinary approach that integrates services from oncologists, nurse 
practitioners, nutritionists, clinical psychologists, and genetics counselors according to 
the patient’s needs (Antill et al., 2005). Regular screening (mammography, MRI, CBE, 
ultrasound, and BSE), as well as integrated services are useful in detecting breast cancer 
in women with a familial risk of breast cancer (Chart & Franssen, 1997; Kuhl et al., 
2010; Larsson et al., 1996; Tabar et al., 1985). Although believed to provide benefit, 
extant research has not established the psychological effects of attending regular 
surveillance appointments. Additionally, existing research has not shed light on why 
some high-risk women do not return for even a second visit in spite of the significant 
upside of adhering to regular surveillance. 
One of the more significant appreciations to be gained from this research is that 
while some similarities may be shared, as a population, women at high risk for breast 
cancer are enormously complex. This was evident among a group of women limited to 
daughters of breast cancer patients, a study sample some might be considered as less 
heterogeneous in nature. An approach that proved useful in this research may also be 
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useful in future studies in efforts to disentangle the complexities that will likely be 
encountered. In particular, insight afforded by the results of these studies is the value and 
need to consider moderating variables when examining predictors of a phenomena. Much 
of the previous literature in this area, examining reattendance as well as adjustment 
among high-risk women, has not yielded robust results. It might be the case that from the 
same data that originally provided finding best described as equivocal, if it were 
reanalyzed with consideration of moderating factors, perhaps the results would be 
something theoretically and clinically meaningful. In both studies, mother’s survival 
status was modeled in interaction terms with other predictors, and this alone led to 
interesting and useful results. This dataset, and most others as well, likely have not yet 
been fully potentiated and a small bit of additional work and creative thinking to identify 
potential moderators could lead to remarkable findings. 
Taken together, the findings from these studies also underscore the need for 
clinicians to attend to those patients who we would not expect to be distressed, and even 
those who deny feeling distress whatsoever. For example, as discussed in Chapter 2, 
despite what “reasonable” expectations may dictate, it is sometimes the case that 
daughters whose mothers survived experience greater distress. In Chapter 3, the 
curvilinear relationship between anxiety and reattendance showed high levels of distress 
to be associated with a decreased likelihood of reattendance. Given the effectiveness of 
surveillance programs are contingent on continued attendance, this is concerning, and 
points towards the usefulness of screening measures to identify patients in immediate 
psychological need. While patients reporting elevated levels of anxiety are a matter of 
concern for physicians and psychologists alike, the quadratic, inverted “U” pattern of the 
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association between anxiety and reattendance also helps to bring attention to another 
subgroup of at risk women represented on the opposite side of the graph who should be 
of equal if not perhaps greater concern.  
These patients are in some ways at greater risk because they do not demonstrate 
distress or convey a need for support that oftentimes catches the attention of mental 
health clinicians. To block or deny anxiety in a setting where at least moderate feelings of 
anxiety are normative is troubling but a challenge to deal with because these patients will 
not be as receptive to offers of support. Because women endorsing very minimal anxiety 
appear at risk for not returning for follow-up, support in the form of a phone call from the 
office staff to schedule timely follow-ups or provide reminders of upcoming 
appointments may is a good starting place. Another underserved but at risk patient group 
highlighted by this research is the half of women not returning for a follow-up visit at the 
high-risk clinic. It is unfortunate that many of these women, who appear to be 
experiencing significant distress, perhaps to a greater degree than patients who reattend, 
are also those least accessible to mental health clinicians by virtue of their absence.  
Beyond empirical, academic and theoretical contributions, an equally if not more 
important contribution of these studies is to resensitize clinicians and health professionals 
to the reality that the patients most in need of support and healing oftentimes are those 
who do not voice their distress or appear to be experiencing difficulty. As with the half of 
the sample of high-risk women who did not reattend, there are opportunities to identify 
and offer support to the distressed who are less visible, and even just having a renewed 
appreciation of the potential need of such patients will allow to be better clinicians to 
more of the patients who really need us. 
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